VANCOUVER, BC / ACCESS Newswire / November 25, 2025 /Variational AI, a leading innovator in generative artificial ...

Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...

Artificial intelligence (AI) is revolutionising how scientists study cancer and Type 1 diabetes and discover ways to fight them.

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

Nil Adell-Mill is pioneering a new era of chemistry by teaching machines to innovate through biology-inspired models, ...

Explore the role of AI in drug discovery and how automation enhances precision and speed in modern scientific research.

In multidisciplinary settings, AI summarizes evidence for each specialist and speeds up consensus. Trials show it can help ...

Quantum technology is rapidly emerging as one of the most revolutionary scientific advances of the 21st century. Unlike classical technologies, which Quantum technology is rapidly emerging as one of ...

A new AI model called popEVE can predict how likely each variant in a patient’s genome is to cause disease. The team is ...

ToxPredictor accurately predicts drug induced liver injury (DILI) to offer a valuable “go/no-go” tool in clinical decision making.

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...